Categories: DesignDevelopment
Alpha Fusionæ ªå¼ä¼ç¤¾ã¯ãã¢ã¹ã¿ãã³-211ï¼At-211ï¼ãåºç¤ã¨ããæ¨çã¢ã«ãã¡çæ³ï¼Targeted Alpha Therapy, TATï¼ã®å®ç¨åãç®æã æ¥æ¬çºã®ãã¤ãªãã¯ããã¸ã¼ä¼æ¥ã§ã ç§ãã¡ã¯ã人ã
ã®å¥åº·ã®ããã«ã¢ã«ãã¡ç·æ²»çã®å¯è½æ§ã解ãæ¾ã¤ãã¨ããç念ã®ãã¨ãæ¾å°åå¦ãåµè¬ãè¨åºå»å¦ã®ç¥è¦ãçµéããé©æ°çãªæ¾å°æ§å»è¬åã®éçºã«åãçµãã§ãã¾ãã
Investors 1
Mentions in press and media 5
| Date | Title | Description |
| 31.10.2025 | Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Differentiated Thyroid Cancer | – Aiming to establish af-001 as a new therapeutic option for radioactive iodine (RAI)-naïve patients with differentiated thyroid cancer –
TOKYO, Oct. 31, 2025 /PRNewswire/ -- Alpha Fusion Inc. (Headquarters: Chiyoda-ku, Tokyo; CEO: Sunao Fu... |
| 01.07.2025 | Five Japanese Startups to Be Featured in 2025 Innovation Showcase | 2025 Japan - U.S. Innovation Awards
Honorees to Present at Japan–U.S. Innovation Awards Symposium at Stanford University SAN FRANCISCO, CA, UNITED STATES, June 30, 2025 /EINPresswire.com/ -- Japan-U.S. Innovation Awards Program announced to... |
| 30.06.2025 | Alpha Fusion, Inc. and Curadh MTR, Inc. to Enter into Strategic Partnership to Advance Global Development of Astatine-211 Based Radiopharmaceuticals | TOKYO, June 30, 2025 /PRNewswire/ -- Alpha Fusion, Inc. ("Alpha Fusion") and Curadh MTR Inc. ("Curadh") announced plans to enter a strategic partnership, including a Joint Venture to broadly advance the global developmen... |
| 09.10.2024 | Alpha Fusion Accelerates Astatine-based Drug Discovery with Series B Funding | OSAKA, Japan, Oct. 9, 2024 /PRNewswire/ -- Alpha Fusion, Inc. (CEO: Sunao Fujioka, headquartered in Kita-ku, Osaka), has raised a total of ¥1.02 billion through a Series B funding round. The round was led by SBI Investment Co., Ltd. and OSA... |
| - | Alpha Fusion | “Alpha Fusion Inc. is a clinical-stage startup committed to transforming cancer treatment through the design and development of powerful and precise radiopharmaceuticals.” |
Reviews 0
